INCANNEX HEALTHCARE INC (IXHL) Stock Price, Quote, News and Overview
NASDAQ:IXHL - Nasdaq - US45333F1093 - Common Stock - Currency: USD
IXHL Quote, Performance and Key Statistics
NASDAQ:IXHL (6/30/2025, 11:21:08 AM)
0.2105
+0.01 (+3.54%)
The current stock price of IXHL is 0.2105 USD. In the past month the price decreased by -7.59%. In the past year, price decreased by -93.08%.
IXHL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 56.55 | 737.44B | ||
| JNJ | JOHNSON & JOHNSON | 15.11 | 365.39B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.68 | 306.28B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.52 | 238.35B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 15.83 | 216.01B | ||
| MRK | MERCK & CO. INC. | 10.13 | 198.10B | ||
| PFE | PFIZER INC | 7.59 | 138.50B | ||
| SNY | SANOFI-ADR | 10.61 | 117.71B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.35 | 94.84B | ||
| GSK | GSK PLC-SPON ADR | 8.5 | 77.88B | ||
| ZTS | ZOETIS INC | 25.95 | 69.56B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 64.35 | 48.25B |
Related stock screener links
About IXHL
Company Profile
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. The company is headquartered in New York City, New York and currently employs 9 full-time employees. The company went IPO on 2022-03-18. The firm is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
Company Info
INCANNEX HEALTHCARE INC
18 East 50th Street, 5th Floor
New York City NEW YORK US
Employees: 9
INCANNEX HEALTHCARE INC / IXHL FAQ
What is the stock price of INCANNEX HEALTHCARE INC today?
The current stock price of IXHL is 0.2105 USD. The price increased by 3.54% in the last trading session.
What is the ticker symbol for INCANNEX HEALTHCARE INC stock?
The exchange symbol of INCANNEX HEALTHCARE INC is IXHL and it is listed on the Nasdaq exchange.
On which exchange is IXHL stock listed?
IXHL stock is listed on the Nasdaq exchange.
What is INCANNEX HEALTHCARE INC worth?
INCANNEX HEALTHCARE INC (IXHL) has a market capitalization of 6.20M USD. This makes IXHL a Nano Cap stock.
How many employees does INCANNEX HEALTHCARE INC have?
INCANNEX HEALTHCARE INC (IXHL) currently has 9 employees.
What are the support and resistance levels for INCANNEX HEALTHCARE INC (IXHL) stock?
INCANNEX HEALTHCARE INC (IXHL) has a resistance level at 0.22. Check the full technical report for a detailed analysis of IXHL support and resistance levels.
Is INCANNEX HEALTHCARE INC (IXHL) expected to grow?
The Revenue of INCANNEX HEALTHCARE INC (IXHL) is expected to grow by 3817.05% in the next year. Check the estimates tab for more information on the IXHL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INCANNEX HEALTHCARE INC (IXHL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IXHL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IXHL, evaluating the profitability, health, valuation and growth aspects
- INCANNEX HEALTHCARE INC (IXHL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INCANNEX HEALTHCARE INC (IXHL) Sales and EPS estimates to see what analysts future expectations are.
- INCANNEX HEALTHCARE INC (IXHL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INCANNEX HEALTHCARE INC (IXHL) Insider and Institutional Ownership to learn about the owners and their transactions.
- INCANNEX HEALTHCARE INC (IXHL) Stock Chart to make your own analysis
- INCANNEX HEALTHCARE INC (IXHL) Latest news and press-releases to stay up to date.
Does INCANNEX HEALTHCARE INC (IXHL) stock pay dividends?
IXHL does not pay a dividend.
When does INCANNEX HEALTHCARE INC (IXHL) report earnings?
INCANNEX HEALTHCARE INC (IXHL) will report earnings on 2025-09-26.
What is the Price/Earnings (PE) ratio of INCANNEX HEALTHCARE INC (IXHL)?
INCANNEX HEALTHCARE INC (IXHL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.4).
What is the Short Interest ratio of INCANNEX HEALTHCARE INC (IXHL) stock?
The outstanding short interest for INCANNEX HEALTHCARE INC (IXHL) is 23.82% of its float. Check the ownership tab for more information on the IXHL short interest.
IXHL Technical Analysis
IXHL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IXHL. IXHL has a bad profitability rating. Also its financial health evaluation is rather negative.
IXHL Financial Highlights
Over the last trailing twelve months IXHL reported a non-GAAP Earnings per Share(EPS) of -1.4. The EPS increased by 64.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -214.35% | ||
| ROE | -2466.94% | ||
| Debt/Equity | 3.9 |
IXHL Ownership and Analysts
For the next year, analysts expect an EPS growth of -116.51% and a revenue growth 3817.05% for IXHL